Alpha Sophia Founder and CEO Paul-Lukas Hoffschmidt explains how the company's software diverges from competitors in healthcare commercial intelligence, by focusing on smaller medtech innovators.
How do organizations optimize and scale business intelligence? Here are five basic steps to consider when developing dashboards to assess your operational, financial and quality components within the care at home industry.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
A flurry of digital health IPO filings spurred Rock Health to do a survey asking participants which company will file to go public next.
A new report by technology M&A tracker CB Insights on technology exits seems to dovetail with some digital health trends. Internet and mobile companies accounted for 80 percent of venture-backed exits. Although digital health continues to be more a funding story than an exit story, consolidation will continue to increase and mean more dealflow in […]
Wearables in the fitness realm have had a fair share of supporters as part of the quantified self trend but critics note the short-term interest in using these devices when the novelty wears off. The key to adding value is unlocking the data these devices generate and putting it to practical use in healthcare. A […]
Symplur has played a big role in popularizing healthcare hashtags for Twitter to guide people on Twitter looking for specific topic threads, conference conversations and people to follow. It’s recorded 512.9 million tweets spanning 10,000 healthcare topics. Symplur combines big data analysis and its healthcare social media know-how in a new business intelligence channel called […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
A survey of healthcare and life science professionals and investors suggests healthcare M&A activity will surge past 2013 levels when there were 394 deals valued at $97 billion. The report by Bass Berry & Sims and Mergermarket indicates that market disruption, brought on by the Affordable Care Act, will lead to more consolidation deals across […]